Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group.
- DOI
- 10.3389/fonc.2026.1756315
- Published
- 2026
- Container
- Frontiers in oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fonc.2026.1756315,
title = {Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group.},
author = {Yuksel HC and Almuradova E and Buyukahiska O and Yilmaz B and Acar C and Sahin G and Tunbekici S and On S and Akar H and Sahbazlar M and Bayram E and Ergozoglu MA and Tazebay BN and Cabuk D and Kitapli S and Acikgoz Yildiz B and Yildiz S and Cosar R and Akin Telli T and Yilmaz M and Hacibekiroglu I and Sakalar T and Majidova N and Petrovska G and Celebi G and Kalender ME and Rahman M and Akosman C and Danaci Y and Nayir E and Gursoy P and Gokmen E},
year = {2026},
journal = {Frontiers in oncology},
doi = {10.3389/fonc.2026.1756315},
url = {https://doi.org/10.3389/fonc.2026.1756315}
}RIS
TY - JOUR TI - Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group. AU - Yuksel HC AU - Almuradova E AU - Buyukahiska O AU - Yilmaz B AU - Acar C AU - Sahin G AU - Tunbekici S AU - On S AU - Akar H AU - Sahbazlar M AU - Bayram E AU - Ergozoglu MA AU - Tazebay BN AU - Cabuk D AU - Kitapli S AU - Acikgoz Yildiz B AU - Yildiz S AU - Cosar R AU - Akin Telli T AU - Yilmaz M AU - Hacibekiroglu I AU - Sakalar T AU - Majidova N AU - Petrovska G AU - Celebi G AU - Kalender ME AU - Rahman M AU - Akosman C AU - Danaci Y AU - Nayir E AU - Gursoy P AU - Gokmen E PY - 2026 JO - Frontiers in oncology DO - 10.3389/fonc.2026.1756315 UR - https://doi.org/10.3389/fonc.2026.1756315 ER -
APA
HC, Y., E, A., O, B., B, Y., C, A., G, S., S, T., S, O., H, A., M, S., E, B., MA, E., BN, T., D, C., S, K., B, A. Y., S, Y., R, C., T, A. T., M, Y., I, H., T, S., N, M., G, P., G, C., ME, K., M, R., C, A., Y, D., E, N., P, G., & E, G. (2026). Ten-year risk of second primary malignancies among chemotherapy-treated early-stage breast cancer survivors: a multicentre cohort study from the Turkish Oncology Group.. Frontiers in oncology. https://doi.org/10.3389/fonc.2026.1756315
Source records
- pubmed · retrieved 2026-09-26T15:50:46.310Z
- europe-pmc · retrieved 2026-09-26T15:50:46.323Z
- doaj · retrieved 2026-09-26T15:50:46.326Z